Journal article icon

Journal article

Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.

Abstract:

The aim of palliative chemotherapy is to increase survival whilst maintaining maximum quality of life for the individual concerned. It is evident that the survival advantage offered by palliative chemotherapy for metastatic colorectal cancer has increased incrementally with the addition of each newly licensed therapeutic agent. More recently, advances in the field have led to the introduction of targeted monoclonal antibodies, whose benefits are documented in clinical trials and are acknowled...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1586/14737140.8.8.1237
Journal:
Expert review of anticancer therapy More from this journal
Volume:
8
Issue:
8
Pages:
1237-1245
Publication date:
2008-08-01
DOI:
EISSN:
1744-8328
ISSN:
1473-7140
Language:
English
Keywords:
Pubs id:
pubs:236995
UUID:
uuid:e765f689-404a-4ff1-af05-1e56be23dcf7
Local pid:
pubs:236995
Source identifiers:
236995
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP